- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 16 x CLR: CHOLESTEROL(Non-covalent)
CLR.4: 8 residues within 4Å:- Chain A: T.112, A.115, Y.116, S.119, M.948, F.951
- Ligands: CLR.5, CLR.10
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:T.112, A:A.115, A:Y.116, A:F.951
CLR.5: 9 residues within 4Å:- Chain A: I.864, M.948, F.951, S.952, G.955, R.958, F.959
- Ligands: CLR.4, CLR.11
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.864, A:F.959, A:F.959
CLR.6: 4 residues within 4Å:- Chain A: N.839, I.840, L.843, I.848
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:N.839, A:I.840, A:L.843, A:L.843, A:I.848
CLR.7: 5 residues within 4Å:- Chain A: L.843, L.862, V.865, P.866, A.869
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.843, A:L.862, A:V.865, A:P.866
CLR.8: 9 residues within 4Å:- Chain A: L.305, A.308, A.311, L.312, W.315, N.753, S.756, L.757, L.760
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:L.305, A:A.308, A:A.311, A:L.312, A:L.312, A:W.315, A:L.757, A:L.760
- Hydrogen bonds: A:N.753
CLR.9: 5 residues within 4Å:- Chain A: L.67, E.74, Y.117, G.120, I.121
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.67, A:Y.117, A:Y.117
- Hydrogen bonds: A:E.74
CLR.10: 3 residues within 4Å:- Chain A: S.119, G.120
- Ligands: CLR.4
No protein-ligand interaction detected (PLIP)CLR.11: 4 residues within 4Å:- Chain A: A.863, F.959
- Ligands: CLR.5, CLR.12
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:A.863, A:F.959
CLR.12: 6 residues within 4Å:- Chain A: Q.856, L.859, L.862, A.863, F.959
- Ligands: CLR.11
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.859, A:L.862, A:F.959
CLR.13: 6 residues within 4Å:- Chain A: A.220, I.221, L.312, W.315, Y.316
- Ligands: CLR.17
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.221, A:L.312, A:L.312, A:W.315
CLR.14: 6 residues within 4Å:- Chain A: T.845, I.848, I.849, I.852, Y.853
- Ligands: CLR.15
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.848, A:I.849, A:I.852
- Hydrogen bonds: A:Y.853
CLR.15: 4 residues within 4Å:- Chain A: G.723, A.727, F.755
- Ligands: CLR.14
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:A.727
CLR.16: 2 residues within 4Å:- Chain A: F.851, W.855
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.851, A:W.855, A:W.855
CLR.17: 3 residues within 4Å:- Chain A: L.216, A.220
- Ligands: CLR.13
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.216, A:A.220
CLR.18: 5 residues within 4Å:- Chain A: Y.50, Y.130, F.135, H.936
- Ligands: CLR.19
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:Y.130, A:F.135, A:F.135
CLR.19: 5 residues within 4Å:- Chain A: L.46, L.49, V.53, L.56
- Ligands: CLR.18
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.46, A:L.49, A:V.53, A:L.56
- 1 x TA1: TAXOL(Non-covalent)
TA1.20: 16 residues within 4Å:- Chain A: M.69, W.232, Y.307, Y.310, F.336, L.339, I.340, F.343, S.344, Q.347, Q.725, Q.946, Y.953, F.983, M.986, Q.990
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:Y.307, A:F.336, A:L.339, A:I.340, A:F.343, A:F.343, A:F.343, A:F.983, A:F.983, A:M.986, A:Q.990
- Hydrogen bonds: A:Y.307, A:Y.310, A:Q.347, A:Q.725, A:Q.725, A:Q.990
- 2 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
3PE.21: 10 residues within 4Å:- Chain A: M.197, F.200, L.219, P.223, G.226, L.227, A.230, V.345, S.349, I.352
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.200, A:L.219, A:V.345, A:V.345
3PE.22: 7 residues within 4Å:- Chain A: F.37, F.40, M.51, T.55, I.59, F.193, F.355
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:T.55, A:I.59, A:F.193, A:F.193, A:F.355
- Salt bridges: A:K.48
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alam, A. et al., Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. Science (2019)
- Release Date
- 2019-02-27
- Peptides
- Multidrug resistance protein 1: A
UIC2 Fab lightchain: B
UIC2 Fab heavy chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 16 x CLR: CHOLESTEROL(Non-covalent)
- 1 x TA1: TAXOL(Non-covalent)
- 2 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alam, A. et al., Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. Science (2019)
- Release Date
- 2019-02-27
- Peptides
- Multidrug resistance protein 1: A
UIC2 Fab lightchain: B
UIC2 Fab heavy chain: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.